For several decades, Warburg effect has been confirmed to be essential for tumour growth and aggressiveness,1 while pharmacological inhibition of essential glycolytic enzymes, including pyruvate kinase M2 (PKM2) or hexokinase 2 (HK2), is a potential approach for inhibiting aerobic glycolysis of cancers.2 Here, HK2 is linked to neoplasm.